Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 75,453 | 54,475 | 52,436 | 46,007 | 59,077 |
| Cost of Goods | 23,127 | 12,173 | 12,301 | 10,556 | 13,921 |
| Gross Profit | 52,326 | 42,302 | 40,135 | 35,451 | 45,156 |
| Operating Expenses | 35,347 | 32,902 | 33,800 | 32,023 | 32,712 |
| Operating Income | 17,106 | 9,573 | 6,636 | 3,984 | 13,365 |
| Interest Expense | 1,119 | 1,489 | 1,837 | 2,177 | 2,621 |
| Other Income | 1,120 | 1,159 | 1,366 | 1,460 | 1,494 |
| Pre-tax Income | 17,107 | 9,243 | 6,165 | 3,267 | 12,238 |
| Income Tax | 3,669 | 399 | 310 | 293 | -7,067 |
| Net Income Continuous | 13,438 | 8,844 | 5,855 | 2,974 | 19,305 |
| Net Income | $13,438 | $8,844 | $5,855 | $2,974 | $19,305 |
| EPS Basic Total Ops | 0.26 | 0.18 | 0.12 | 0.06 | 0.40 |
| EPS Basic Continuous Ops | 0.27 | 0.18 | 0.12 | 0.06 | 0.40 |
| EPS Diluted Total Ops | 0.26 | 0.17 | 0.12 | 0.06 | 0.40 |
| EPS Diluted Continuous Ops | 0.26 | 0.17 | 0.12 | 0.06 | 0.40 |
| EPS Diluted Before Non-Recurring Items | 0.26 | 0.17 | 0.12 | 0.06 | 0.39 |
| EBITDA(a) | $19,763 | $12,295 | $9,399 | $6,780 | $16,206 |